The Open Source Effect: Akaza Research Provides Insight into Rapid Growth of OpenClinica
OpenClinica, the open source clinical trials software has seen a surge in usage over the past year, according to survey data released today by Akaza Research.
"Our recent survey of the OpenClinica community showed strong expansion in all key measurements of system usage," said Cal Collins, Chief Executive Officer at Akaza. "In the past year we have seen doubling in the number of OpenClinica users and subjects, and a nearly 10-fold increase in regulatory submissions."
The company reports th... Comments (0)Source: Akaza ResearchPosted: Thursday, September 16, 2010Impact of Open Source Software on Clinical Trials Grows With Release of OpenClinica 3.0 Electronic Data Capture Software
Akaza Research is pleased to announce the release of OpenClinica 3.0, the newest version of the world’s most popular open source electronic data capture (EDC) software for clinical trials. This latest production release marks a significant milestone for open source software in the clinical trials field, adding a host of new capabilities designed to further accelerate the adoption of open source into mainstream research. For full article, see http://www.openclinica.org/entities/entity_details.php... Comments (0)Source: Akaza ResearchPosted: Saturday, October 17, 2009